What is the therapeutic response to nonsurgical correction of bilirubin levels in Crigler-Najjar syndrome type 1?

Updated: May 21, 2019
  • Author: Hisham Nazer, MBBCh, FRCP, DTM&H; Chief Editor: BS Anand, MD  more...
  • Print

Therapeutic response varies according to the type of Crigler-Najjar syndrome being treated. Crigler-Najjar syndrome type 1 does not respond to phenobarbital therapy, and patients may require repeated exchange transfusions followed by long-term phototherapy to prevent neurologic complications.

Other therapies include plasmapheresis, hemoperfusion, and the administration of cholestyramine, calcium phosphate, oral agar, and orlistat. [3] An approach to therapy using Sn-protoporphyrin, a heme oxygenase inhibitor, was introduced to prevent an increase in serum bilirubin levels. [4] In patients with Crigler-Najjar syndrome type 1, however, liver transplantation remains the only guaranteed form of therapy. This surgery should occur prior to the onset of kernicterus.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!